ABCD. Welcome to BICI. Petersburg, Virginia

Size: px
Start display at page:

Download "ABCD. Welcome to BICI. Petersburg, Virginia"

Transcription

1 Welcome to BICI Petersburg, Virginia

2 Our Company Our Worldwide Company in Brief: - Focus on Human Pharmaceuticals and Animal Health - Founded 1885 in Ingelheim, Germany - Products marketed in some 150 countries - 39,800 employees - Net sales EUR 12 billion - No. 15 worldwide in terms of sales - Family-owned global corporation Boehringer Ingelheim Businesses: - Prescription Medicines - Consumer Health Care - Biopharmaceuticals - Pharma Chemicals - Animal Health Boehringer Ingelheim Petersburg, Virginia Focus (Pharma Chemicals): - Production of large volume complex active pharmaceutical ingredients (APIs) and preferred second supplier for large volume NCEs Boehringer Ingelheim Petersburg, Virginia Examples of APIs that We Manufacture Dabigatran: Atrial Fibrillation (Pradaxa) Used to reduce the risk of stroke and blood clots in people who have a medical condition called atrial fibrillation. Nevirapine: HIV/AIDS - Reduces levels of HIV-1 Virus (Viramune) Administered during childbirth to prevent the transmission of HIV from mother to child Telmisartan: Hypertension (High Blood Pressure) (Micardis) Provides early morning protection Guaifenesin: Expectorant (Mucinex) Eases coughing and congestion 2

3 BICI, Petersburg The BICI, Petersburg History in Brief: March 22, 1976 Lee Laboratories, Inc. created in Petersburg, Virginia, as a joint venture between A.H. Robins and Pharma-Investment Ltd. December 23, 1977 Boehringer Ingelheim Chemicals, Inc. incorporated under the name Infracorp, Ltd. in Delaware. December 20, 1984 Pharma-Investment transferred shares in Lee Laboratories, Inc. to Boehringer Ingelheim Corporation. May 8, 1991 Boehringer Ingelheim Corporation buys out A.H. Robins and becomes the sole owner of Lee Laboratories, Inc. July 1, 1991 Lee Laboratories, Inc. merged into Infracorp Ltd. Infracorp Ltd. name changed to Lee Laboratories, Inc.; remains a Delaware-based corporation. January 29, 1993 Henley Chemicals, Inc., merged into Lee Laboratories, Inc. Lee Laboratories, Inc., name changed to B.I. Chemicals, Inc. August 27, 1999 B.I. Chemicals, Inc. name changed to Boehringer Ingelheim Chemicals, Inc. 3

4 BICI, Petersburg Our Manufacturing Operations: - Three manufacturing production buildings: Synthesis 1 ( S1 ) Synthesis 3 ( S3 ) Synthesis 5 ( S5 ) Above: Synthesis 5, Production Support Building Left: Synthesis 1 4

5 BICI, Petersburg Our Quality Operations: Production Support Building New Laboratory Opened October Testing of raw materials, intermediates, finished goods and special samples Quality Assurance department 5

6 Our Culture BICI Mission Statement Boehringer Ingelheim Chemicals, Inc. reliably manufacturers and supplies the pharmaceutical industry with advanced, high-quality Active Pharmaceutical Ingredients (APIs). In fulfilling our mission, we improve and save lives. 6

7 Our Culture Our Employee Value Proposition What It Means to Work at Boehringer Ingelheim At Boehringer Ingelheim, we deliver Value through Innovation by living our fundamental principles of Lead & Learn. We have high expectations for our employees. We require employees at all levels of the organization to take initiative, stay connected, grow together, and achieve outstanding results. To enable high performance, we provide opportunities for personal growth, a collaborative and inclusive work environment and exceptional employee benefits. We reward high achievement with recognition, opportunities and competitive pay. We hold ourselves to the highest standard of excellence and count on each other to go the extra mile in everything we do. 7

8 Our Culture Our Values Lead and Learn is about how we work together to achieve our vision. Are we taking initiative? Are we connected? Are we growing together? Are we getting results? These values will guide you as you work with others at BICI and around the world to achieve our Vision: Value through Innovation. 8

9 Our Culture We have been committed to Corporate Social Responsibility for over a century. Our caring culture embraces a broad range of activities for: - our employees and their families our neighbours our society our natural environment For more information: 9

10 Our Culture Our viramune Donation Programme (VDP) Since 2000, we have given free access to nevirapine (viramune ) through the viramune Donation Programme (VDP). We currently donate the product to some 167 programs in 59 countries in Africa, Asia, Latin America and Eastern Europe. So far, at total of more than 1.3 million mother and-child pair doses have been supplied free of charge. 10

11 Our Commitment to Quality Manufacturing BICI is not just about manufacturing and BICI is not just about quality we re dedicated to Quality Manufacturing. This simple but powerful fact is in our heads and our hearts everyday. We ensure everything we do is focused on achieving Quality Manufacturing without exception. We achieve this commitment through focus to initiatives like: Business Process Excellence S ix Sigma Black Belt and Green Belt Projects Business Process Excellence Direct The new 5S manufacturing operation Quality Manufacturing Champions Front-line employees Change Management Leadership Alignment Organizational Alignment Training and Development Communications You will learn more about these initiatives as part of your orientation process. 11

12 Welcome to the Team! Congratulations. You ve made a great choice to join the BICI team! We look forward to your arrival and contributions to our company. In the meantime, if you have any questions, we encourage you to reach out to your hiring manager. 12

ABCD. Welcome to BICI. Petersburg, Virginia

ABCD. Welcome to BICI. Petersburg, Virginia Welcome to BICI Petersburg, Virginia Our Company Our Worldwide Company in Brief: - Focus on Human Pharmaceuticals and Animal Health - Founded 1885 in Ingelheim, Germany - Products marketed in some 150

More information

Annual Press Conference 2012. Business Year 2011

Annual Press Conference 2012. Business Year 2011 Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation

More information

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success Pharmaceuticals Production Services Boehringer Ingelheim Our expertise in world-class contract manufacturing for your success Successful partnership Dr Wolfram Carius Head of Corporate Division Pharmaceuticals

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants which meet any of the following conditions

More information

AFib (short for atrial fibrillation) is the most common type of irregular heartbeat, affecting literally millions of men and women

AFib (short for atrial fibrillation) is the most common type of irregular heartbeat, affecting literally millions of men and women What is atrial fibrillation? AFib (short for atrial fibrillation) is the most common type of irregular heartbeat, affecting literally millions of men and women What is atrial fibrillation? AFib occurs

More information

Committee Approval Date: September 12, 2014 Next Review Date: September 2015

Committee Approval Date: September 12, 2014 Next Review Date: September 2015 Medication Policy Manual Policy No: dru361 Topic: Pradaxa, dabigatran Date of Origin: September 12, 2014 Committee Approval Date: September 12, 2014 Next Review Date: September 2015 Effective Date: November

More information

An integrated global healthcare company

An integrated global healthcare company An integrated global healthcare company 1 A Mission to create healthier communities globally Zydus Cadila is dedicated to life In all its dimensions. Our world is shaped by a passion for innovation, commitment

More information

9/28/15. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. From the AC Forum Centers of Excellence website: Dabigatran, Rivaroxaban, & Apixaban

9/28/15. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. From the AC Forum Centers of Excellence website: Dabigatran, Rivaroxaban, & Apixaban Identify the FDA approved direct oral anticoagulants (DOACs) Linda Kelly, PharmD, PhC, CACP Presbyterian Healthcare Services Distinguish the differences in the dosing of DOACs for various indications Describe

More information

Department of Human Resources FY 2009-2013 Strategic Plan

Department of Human Resources FY 2009-2013 Strategic Plan Department of Human Resources FY 2009-2013 Strategic Plan OUR MISSION, VISION, PHILOSOPHY OUR MISSION In partnership with the University of Arizona community, we attract and engage the world-class human

More information

Boehringer Ingelheim Annual Press Conference 2015. Wednesday, 22 April 2015 Boehringer Ingelheim Center, Ingelheim, Germany

Boehringer Ingelheim Annual Press Conference 2015. Wednesday, 22 April 2015 Boehringer Ingelheim Center, Ingelheim, Germany Boehringer Ingelheim Annual Press Conference 2015 Wednesday, 22 April 2015 Boehringer Ingelheim Center, Ingelheim, Germany The remarks of Andreas Barner Hubertus von Baumbach Members of the Board of Managing

More information

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1 Summary The Dutch market for the pharmaceutical and

More information

How companies leverage quality and quality certifications to achieve competitive advantage

How companies leverage quality and quality certifications to achieve competitive advantage How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for

More information

2016 Edenred-Ipsos Barometer Understand and improve Wellbeing At Work. May 2016

2016 Edenred-Ipsos Barometer Understand and improve Wellbeing At Work. May 2016 2016 Edenred-Ipsos Barometer Understand and improve Wellbeing At Work May 2016 INSIGHTS Wellbeing at work is a growing challenge for companies struggling with an unpredictable economic environment and

More information

Strategic Plan. Page 1 of 6

Strategic Plan. Page 1 of 6 Strategic Plan The following represents the current AACE International Strategic Plan as approved by the Board of Directors at our meeting in April 2014 in Chicago, IL. The Strategic Plan is organized

More information

SUNOVA CREDIT UNION BRAND STRATEGY

SUNOVA CREDIT UNION BRAND STRATEGY SUNOVA CREDIT UNION BRAND STRATEGY A collaboration by Sunova employees and members Collated by the Sunova Marketing Department Introduction What is a brand? Our brand is our promise to our members and

More information

Patient frequently asked questions

Patient frequently asked questions Patient frequently asked questions What is atrial fibrillation?...2 What are dabigatran and rivaroxaban and what are they used for?...2 Which is better, dabigatran or rivaroxaban?...2 For patients with

More information

Implementing Corporate Social Responsibility in Health Sector

Implementing Corporate Social Responsibility in Health Sector Student Research Projects/Outputs No. 003 Implementing Corporate Social Responsibility in Health Sector Sam Lee MBA 2005 China Europe International Business School 699, Hong Feng Road Pudong, Shanghai

More information

APV/IPEC Europe Excipient Conference 2014

APV/IPEC Europe Excipient Conference 2014 APV/IPEC Europe Excipient Conference 2014 An update on regulatory and application developments 23 to 24 September 2014 Düsseldorf, Germany Course No. 3128 Marketing Düsseldorf Target Group This conference

More information

Yusen Logistics (Italy) S.p.A. A Company Profile

Yusen Logistics (Italy) S.p.A. A Company Profile Yusen Logistics (Italy) S.p.A. A Company Profile Yusen Logistics Global - Mission Statement Mission Contribute to global economic development and maximize corporate value by earning the trust of our customers

More information

How To Get A Dose Of Bayer Healthcare'S Oral Anticoagulant, Xarelto

How To Get A Dose Of Bayer Healthcare'S Oral Anticoagulant, Xarelto News Release FOR UK HEALTHCARE MEDIA ONLY Bayer HealthCare Bayer plc Bayer House Strawberry Hill Newbury Berkshire, RG14 1JA www.bayer.co.uk Bayer s Xarelto (rivaroxaban) Recommended by CHMP for EU Approval

More information

Over 60,000 people helping customers manage risk in more than 170 countries.

Over 60,000 people helping customers manage risk in more than 170 countries. Zurich at a Glance Over 60,000 people helping customers manage risk in more than 170 countries. Zurich at a Glance 1 Since 1872 We ve been in the business of insurance. Reaching out from our home market

More information

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatment

More information

Annual Report 2007. nopq

Annual Report 2007. nopq Annual Report 2007 Value Value through through Innovation nopq Financial Highlights Boehringer Ingelheim group of companies Amounts in millions of EUR, unless otherwise indicated 2007 2006 change Net sales

More information

MANAGING THE COMPLEXITIES OF GLOBAL PHARMACEUTICAL SOURCING

MANAGING THE COMPLEXITIES OF GLOBAL PHARMACEUTICAL SOURCING DPT Thought Leadership Issue 10 MANAGING THE COMPLEXITIES OF GLOBAL PHARMACEUTICAL SOURCING With the increased globalization and complexity of the pharmaceutical supply chain, managing the sourcing of

More information

Medication Policy Manual. Topic: Eliquis, apixaban Date of Origin: July 12, 2013. Committee Approval Date: July 11, 2014 Next Review Date: July 2015

Medication Policy Manual. Topic: Eliquis, apixaban Date of Origin: July 12, 2013. Committee Approval Date: July 11, 2014 Next Review Date: July 2015 Medication Policy Manual Policy No: dru313 Topic: Eliquis, apixaban Date of Origin: July 12, 2013 Committee Approval Date: July 11, 2014 Next Review Date: July 2015 Effective Date: August 1, 2014 IMPORTANT

More information

Welcome to the World s most advanced biorefinery! Majvi Brandbu Business Development Manager

Welcome to the World s most advanced biorefinery! Majvi Brandbu Business Development Manager Welcome to the World s most advanced biorefinery! Majvi Brandbu Business Development Manager Global presence Borregaard 2011 Turnover: NOK 4 bill. 1200 employees in 20 countries Main office Sales office

More information

Breakfast symposium: From hospital to home - the focus on the patient

Breakfast symposium: From hospital to home - the focus on the patient Breakfast symposium: From hospital to home - the focus on the patient Nadya Hamedi DARZI Fellow UCLPartners and Barts Health NHS Trust in collaboration with North Central London Local Pharmaceutical Committee

More information

Anticoagulation in Atrial Fibrillation Patient information

Anticoagulation in Atrial Fibrillation Patient information Anticoagulation in Atrial Fibrillation Patient information RSBAY013 Anticoag A5 V2.indd 1 21/02/2014 17:13 Introduction This leaflet will help you understand your new medicine. Your new medicine is commonly

More information

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog. Quality Thinking in other Industries Dominic Parry Inspired Pharma Training WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.com Welcome The traditional focus on quality Quality in the eyes of GMP

More information

Brand Name Marevan Pradaxa Xarelto Eliquis

Brand Name Marevan Pradaxa Xarelto Eliquis Medicines for stroke prevention in atrial fibrillation Choosing the right one for you Atrial fibrillation (AF) is a condition that affects the heart, causing it to beat irregularly and too fast. When this

More information

SIX SIGMA IN HOSPITAL AND HEALTH CARE MANAGEMENT

SIX SIGMA IN HOSPITAL AND HEALTH CARE MANAGEMENT SIX SIGMA IN HOSPITAL AND HEALTH CARE MANAGEMENT Competition in health care sector are forcing healthcare organizations to look for new ways and means for improving their processes. This for improving

More information

Bachelor s Degree. in Manufacture of Medicinal Products (DT291) Full Time Part Time Online. www.getreskilled.com

Bachelor s Degree. in Manufacture of Medicinal Products (DT291) Full Time Part Time Online. www.getreskilled.com Bachelor s Degree in Manufacture of Medicinal Products (DT291) Full Time Part Time Online www.getreskilled.com Contents 1. Welcome 2. Program Overview 3. Program Content 4. Core Modules 5. Optional Modules

More information

Z E N T I VA AT G L A N C E. We a i m t o b e y o u r va l u e d ge n e r i c s partner

Z E N T I VA AT G L A N C E. We a i m t o b e y o u r va l u e d ge n e r i c s partner Z E N T I VA AT G L A N C E We a i m t o b e y o u r va l u e d ge n e r i c s partner Poland Czech Republic Germany United Kingdom France Portugal Switzerland Italy Slovenia Estonia Latvia Lithuania Slovakia

More information

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you Medicines for stroke prevention in atrial fibrillation Choosing the right one for you Atrial fibrillation (AF) is a condition that affects the heart, causing it to beat irregularly and too fast. When this

More information

The Biesterfeld Group

The Biesterfeld Group The Biesterfeld Group The Biesterfeld Company LISTENING AND ACTING If there s one thing that has stayed with us since 1906, it s the habit of listening and acting. Our family tradition of trustful, customer

More information

Elisabetta Toso, MD Dipartment of Medical Sciences University of Turin

Elisabetta Toso, MD Dipartment of Medical Sciences University of Turin Security and efficacy of Rivaroxaban in real life in the prevention of the stroke in non valvular AF patients: presentation of the results of the international study Xantus Elisabetta Toso, MD Dipartment

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

NEW CHEMICAL ENTITIES

NEW CHEMICAL ENTITIES NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product

More information

Barco Marketing Case Analysis

Barco Marketing Case Analysis Barco Marketing Case Analysis I. Position Statement: Over the past few months, many events have led Barco Projection Systems to be confronted with an important decision: Barco needs to continue its development

More information

Lacidipine 2 mg Film-Coated Tablets PL 08553/0502. Lacidipine 4 mg Film-Coated Tablets PL 08553/0503. UK Public Assessment Report

Lacidipine 2 mg Film-Coated Tablets PL 08553/0502. Lacidipine 4 mg Film-Coated Tablets PL 08553/0503. UK Public Assessment Report Lacidipine 2 mg Film-Coated Tablets PL 08553/0502 Lacidipine 4 mg Film-Coated Tablets PL 08553/0503 UK Public Assessment Report TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 4 Steps taken

More information

Rx-360 An International Pharmaceutical Supply Chain Consortium

Rx-360 An International Pharmaceutical Supply Chain Consortium Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)

More information

International Business Central European Business Realities UNIVERSITY OF ECONOMICS, PRAGUE, CZECH REPUBLIC

International Business Central European Business Realities UNIVERSITY OF ECONOMICS, PRAGUE, CZECH REPUBLIC International Business Central European Business Realities UNIVERSITY OF ECONOMICS, PRAGUE, CZECH REPUBLIC UNIVERSITY OF ECONOMICS, PRAGUE The University of Economics, Prague (Vysoká škola ekonomická v

More information

Personal Invitation. 5 th Siegfried Symposium Presents. the 2012 Siegfried Medalist and the 2012 SCS Sandmeyer Prize Winners

Personal Invitation. 5 th Siegfried Symposium Presents. the 2012 Siegfried Medalist and the 2012 SCS Sandmeyer Prize Winners Personal Invitation 5 th Siegfried Symposium Presents the 2012 Siegfried Medalist and the 2012 SCS Sandmeyer Prize Winners October 5, 2012 Metropol Zurich, Switzerland Dear Visitors, Dear Colleagues, and

More information

Consulting Performance, Rewards & Talent. Making Employee Engagement Happen: Best Practices from Best Employers

Consulting Performance, Rewards & Talent. Making Employee Engagement Happen: Best Practices from Best Employers Consulting Performance, Rewards & Talent Making Employee Engagement Happen: Best Practices from Best Employers The Challenge Companies across the globe are taking the initiative to administer and manage

More information

Project Management Office Charter

Project Management Office Charter Old Dominion University Office of Computing and Communication Services Project Management Office Charter Version: 1.0 Last Update: February 18, 2010 Created By: Anthony Fox, PMP OCCS Project Management

More information

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Family physician with Rivergrove Medical Clinic Practice in the north end since 1985 Medical Director of the Wellness

More information

What to Know About. Atrial Fibrillation

What to Know About. Atrial Fibrillation Atrial Fibrillation What to Know About Atrial Fibrillation Understanding Afib Atrial fibrillation, or Afib, is a condition in which the heart beats irregularly speeding up or slowing down, or beating too

More information

Cover for pregnancy and childbirth. Cover for pregnancy and childbirth 20 July 2014 Page 1 of 17

Cover for pregnancy and childbirth. Cover for pregnancy and childbirth 20 July 2014 Page 1 of 17 Cover for pregnancy and childbirth 2014 Cover for pregnancy and childbirth 20 July 2014 Page 1 of 17 How we cover pregnancy and childbirth in 2014 The Maternity Benefit covers day-to-day and in-hospital

More information

Prozessautomatisierung mit SAP Netweaver BPM bei Boehringer Ingelheim 20. Mai 2014

Prozessautomatisierung mit SAP Netweaver BPM bei Boehringer Ingelheim 20. Mai 2014 Prozessautomatisierung mit SAP Netweaver BPM bei Boehringer Ingelheim 20. Mai 2014 Dr. Torsten Grünewald Global Business Services / Process Management Boehringer Ingelheim Pharma GmbH&Co KG Boehringer

More information

China has become the world s factory, second only to the USA in terms of CO 2 emissions among major industrial countries.

China has become the world s factory, second only to the USA in terms of CO 2 emissions among major industrial countries. PEPTIDES & PROTEINS When it comes to peptide manufacturing, we are all Chinese Jim Hampton, executive vice-president of business development at AmbioPharm, describes sourcing trends for raw materials,

More information

Multitude of opportunities for Finnish pharmaceutical industry in India

Multitude of opportunities for Finnish pharmaceutical industry in India 1 Multitude of opportunities for Finnish pharmaceutical industry in India Dr. Esa Heinonen, MD, PhD Senior Advisor Business Development and Support Orion Pharma 2 3 Challenges of pharmaceutical industry

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

Annual Report 2006. Value through Innovation. nopq

Annual Report 2006. Value through Innovation. nopq Annual Report 2006 Value through Innovation nopq Financial Highlights Boehringer Ingelheim group of companies Amounts in millions of EUR, unless otherwise indicated 2006 2005 change Net sales 10,574 9,535

More information

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? Patient decision aid Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? http://guidance.nice.org.uk/cg180/patientdecisionaid/pdf/english Published: June 2014 About

More information

QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES

QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES Why are Pharmacopoeias so important in a globalised world? Pharmacopoeias have historically provided collections of medical recipes intended to ensure accurate

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE June 22, 2015 SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Anticoagulants Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

FOCUS MONASH. Strategic Plan 2015 2020

FOCUS MONASH. Strategic Plan 2015 2020 F CUS FOCUS MONASH Strategic Plan 2015 2020 2 Vice-Chancellor s Introduction 4 Over the last half century, Monash University has forged a path that reflects the ambitions of its beginnings and signals

More information

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate

More information

Cardiology Update 2014

Cardiology Update 2014 Cardiology Update 2014 Update on the Novel Oral Anticoagulants (NOACS) Raymond Kawasaki, MD AMG Cardiology December 6, 2014 Disclosures I have no disclosures relevant to this presentation Contents I. The

More information

Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions

Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions What is atrial fibrillation?...2 What are dabigatran, rivaroxaban and apixaban and what are they used for?...2

More information

The Receivables Finance Industry

The Receivables Finance Industry Want to take part? The International Factors Group is the trade association that fully represents and promotes the interests of the factoring, invoice financing and asset based lending industry on a global

More information

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,

More information

purplepromise.fedex.com

purplepromise.fedex.com purplepromise.fedex.com We continue to change the way the world works and lives by doing one simple thing: Placing our customers at the center of all we do. This takes commitment a shared way of thinking,

More information

Shutterstock TACstock

Shutterstock TACstock Shutterstock TACstock 10 Introduction Since 2000, the IDF Diabetes Atlas has detailed the extent of diabetes and this seventh edition shows how it is impacting every country, every age group and every

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

Public Assessment Report. Decentralised Procedure

Public Assessment Report. Decentralised Procedure Public Assessment Report Decentralised Procedure TELMISARTAN DR REDDY S 20 MG TABLETS TELMISARTAN DR REDDY S 40 MG TABLETS TELMISARTAN DR REDDY S 80 MG TABLETS (telmisartan) Procedure No: UK/H/5034/001-003/DC

More information

IMCD reports strong results for 2014

IMCD reports strong results for 2014 IMCD reports strong results for 2014 Rotterdam, The Netherlands 11 March 2015 - IMCD N.V. ( IMCD or Company ), a leading international speciality chemicals-focused distributor, today announces the 2014

More information

Science For A Better Life. Engaging employees in environmental sustainability B-Green Program: William Malpass, Bayer NZ Ltd

Science For A Better Life. Engaging employees in environmental sustainability B-Green Program: William Malpass, Bayer NZ Ltd Science For A Better Life Engaging employees in environmental sustainability B-Green Program: William Malpass, Bayer NZ Ltd Business Areas Bayer Excellence in Communication Awards Page 2 112,500 employees

More information

11 Serious and life-threatening side effects can occur while taking EVISTA. These include 12 blood clots and dying from stroke:

11 Serious and life-threatening side effects can occur while taking EVISTA. These include 12 blood clots and dying from stroke: 1 1 BNL 3123 AMP 2 Medication Guide 3 EVISTA (E-VISS-tah) 4 (raloxifene hydrochloride) 5 Tablets for Oral Use 6 Read the Medication Guide that comes with EVISTA before you start taking it and each time

More information

Discover Teach Heal. UC Irvine Health: Advancing the Future of Healthcare Nursing Strategic Plan FY2011 FY2015 Nursing Strategic Plan Summary

Discover Teach Heal. UC Irvine Health: Advancing the Future of Healthcare Nursing Strategic Plan FY2011 FY2015 Nursing Strategic Plan Summary UC Irvine Health: Advancing the Future of Healthcare Nursing Strategic Plan FY2011 FY2015 Nursing Strategic Plan Summary Mission Statement (Our purpose) Discover Teach Heal Vision Statement (Our aspiration)

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

WELCOME. Leadership. Academy. Become the Leader you are Called to Be. www.qualfonuniversity.com

WELCOME. Leadership. Academy. Become the Leader you are Called to Be. www.qualfonuniversity.com U N I V E R S I T Y WELCOME Leadership Academy Become the Leader you are Called to Be Supervisor Readiness Certification Supervisor Certification Leadership Certification www.qualfonuniversity.com Dear

More information

HIGHWAYS ENGLAND STRATEGIC BUSINESS PLAN OVERVIEW 2015-2020

HIGHWAYS ENGLAND STRATEGIC BUSINESS PLAN OVERVIEW 2015-2020 HIGHWAYS ENGLAND STRATEGIC BUSINESS PLAN OVERVIEW 05-00 STRATEGIC ROAD NETWORK 4,00 miles of motorways and major A roads A billion tonnes of freight transported each year 4 million people drive on the

More information

JOB(06)/35 24 February 2006 MARKET ACCESS FOR NON-AGRICULTURAL PRODUCTS. Open Access to Enhanced Healthcare

JOB(06)/35 24 February 2006 MARKET ACCESS FOR NON-AGRICULTURAL PRODUCTS. Open Access to Enhanced Healthcare 24 February 2006 Negotiating Group on Market Access MARKET ACCESS FOR NON-AGRICULTURAL PRODUCTS Open Access to Enhanced Healthcare Communication from Singapore, the United States and Switzerland Introduction

More information

(Atrial Fibrillation) What You and Your Family Should Know

(Atrial Fibrillation) What You and Your Family Should Know Afib (Atrial Fibrillation) What You and Your Family Should Know BRING THIS BOOKLET TO YOUR NEXT DOCTOR S VISIT. Getting Started This guide will: 1. Provide you with information to help you and your family

More information

Introduction. More time to run their business, Less HR cost to reinvest back to their organization and

Introduction. More time to run their business, Less HR cost to reinvest back to their organization and Introduction The Barbelo Group is a one stop Human Resources Outsourcing, Staffing and Consulting firm. It is the only outsource and consulting HR organization in the industry to apply Six Sigma methodologies

More information

Leadership and Management Competencies

Leadership and Management Competencies Leadership and Management Competencies 0 The Saskatchewan Public Service Vision: The Best Public Service in Canada Our Commitment to Excellence Dedicated to service excellence, we demonstrate innovation,

More information

Executive Summary. Motive for the request for advice

Executive Summary. Motive for the request for advice Executive Summary Motive for the request for advice Currently nearly 400,000 people in the Netherlands are being treated with anticoagulants of a type Vitamin K antagonists (VKAs). Although VKAs are very

More information

ARHINFUL LORETTA ABA A (844974) SAM PETRA MENSIMAA (844794) AHMED SK ASHIF (843888)

ARHINFUL LORETTA ABA A (844974) SAM PETRA MENSIMAA (844794) AHMED SK ASHIF (843888) GROUP MEMBERS ARHINFUL LORETTA ABA A (844974) SAM PETRA MENSIMAA (844794) AHMED SK ASHIF (843888) P W 1 THE HRM BUSINESS MODEL OF ENTERPRISE LIFE ASSURANCE COMPANY GHANA (ELAC) CONTENT ENTERPRISE LIFE

More information

Atrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid

Atrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid Atrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid Atrial fibrillation (AF) increases your risk of having a stroke (a blood clot in the brain). From

More information

Rethinking the Haverford College Chemistry Department: Curriculum and Teaching Methods

Rethinking the Haverford College Chemistry Department: Curriculum and Teaching Methods Introduction to Critical Feminist Studies Paper #3 December 8, 2008 Rethinking the Haverford College Chemistry Department: Curriculum and Teaching Methods About the Author: This is written from the perspective

More information

THE TOP TEN CAUSES OF DEATH

THE TOP TEN CAUSES OF DEATH FACT SHEET THE TOP TEN CAUSES OF DEATH THE TEN LEADING CAUSES OF DEATH BY BROAD INCOME GROUP 2002 High-income countries Deaths in millions % of deaths Coronary heart 1.34 17.1 Stroke and other s 0.77 9.8

More information

Is ITIL All Theory and No Practice?

Is ITIL All Theory and No Practice? Is ITIL All Theory and No Practice? Carolyn M. Hennings PMP, IT Service Manager ITIL is a Registered Trade Mark, and a Registered Community Trade Mark of the Office of Government Commerce, and is Registered

More information

The Coming Global Digital Stock Market

The Coming Global Digital Stock Market International Finance 2:3, 1999: pp. 441 447 The Coming Global Digital Stock Market Frank G. Zarb National Association of Securities Dealers, Inc. I. Introduction There is little doubt that the stock market

More information

Delivering your brand promise

Delivering your brand promise A few tips on Delivering your brand promise What is a brand promise? A high-level brand promise (sometimes called brand essence) is an articulation of what target customers can expect from their experience

More information

Dummy Ribbons. BMI_DUMRIBBS_v12_11112013_web

Dummy Ribbons. BMI_DUMRIBBS_v12_11112013_web Dummy Ribbons High Density Seed High Density Spacer High Density Seed Stainless Steel Cable BMI_DUMRIBBS_v12_11112013_web Best Medical can provide any standard or customized configuration made to your

More information

What Is Patient Safety?

What Is Patient Safety? Patient Safety Research Introductory Course Session 1 What Is Patient Safety? David W. Bates, MD, MSc External Program Lead for Research, WHO Professor of Medicine, Harvard Medical School Professor of

More information

By Wavepac Infosystems LLC Dubai UAE (In coordination with AIQM India)

By Wavepac Infosystems LLC Dubai UAE (In coordination with AIQM India) By Wavepac Infosystems LLC Dubai UAE (In coordination with AIQM India) GE s ex CEO Jack Welch s words. Six sigma has changed the DNA at GE it is the way that GE works in everything that GE does in every

More information

Company Profile. docount GmbH. pubpress. docount GmbH > www.docount.com > info@docount.ch > +41 61 723 95 95 (P) > +41 61 723 95 96 (F)

Company Profile. docount GmbH. pubpress. docount GmbH > www.docount.com > info@docount.ch > +41 61 723 95 95 (P) > +41 61 723 95 96 (F) docount GmbH pubpress docount GmbH Your partner in Performance Management History In the early nineties, the Swiss companies CIBA AG and SANDOZ AG decided to collect data for all their sites worldwide

More information

Mark Rohlfing. Vice President of Operations Almac Clinical Services Souderton, Pennsylvania

Mark Rohlfing. Vice President of Operations Almac Clinical Services Souderton, Pennsylvania Mark Rohlfing Vice President of Operations Almac Clinical Services Souderton, Pennsylvania Confidential Almac Group 2014 Who We Are Almac is a global drug development services provider. Our mission is

More information

Answers to some frequently asked questions THE YOUTH FOR EUROPE GROUP INSURANCE PLAN

Answers to some frequently asked questions THE YOUTH FOR EUROPE GROUP INSURANCE PLAN Answers to some frequently asked questions THE YOUTH FOR EUROPE GROUP INSURANCE PLAN A tailor-made plan designed to provide worldwide protection 24 hours a day for Participants, access to first rate medical

More information

Private Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS

Private Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS How To Apply For IFC Financing About IFC A company or entrepreneur seeking to establish a new health project or expand an IFC, a member of the World Bank Group, is the largest global development existing

More information

STRATEGY UPDATE 2 MARCH 2016

STRATEGY UPDATE 2 MARCH 2016 STRATEGY UPDATE 2 MARCH 2016 Portfolio Focus on Attractive Growth and Margin Opportunities André Lacroix, CEO Intertek Group plc, is today announcing a strategic update outlining the Group s plan to deliver

More information

Promoting Family Planning

Promoting Family Planning Promoting Family Planning INTRODUCTION Voluntary family planning has been widely adopted throughout the world. More than half of all couples in the developing world now use a modern method of contraception

More information

2011 R&D/Innovation and Product Development Priorities Survey Results

2011 R&D/Innovation and Product Development Priorities Survey Results Americas growth team membership 0 R&D/Innovation and Product Development Priorities Survey Results Executive Summary... What is the Growth Team Membership... Survey Purpose and Respondents... External

More information

SALES TRAINING INTERNATIONAL LTD FACT SHEET. Six Sigma

SALES TRAINING INTERNATIONAL LTD FACT SHEET. Six Sigma Six Sigma This fact sheet introduces the Six Sigma quality technique, and presents action points for its implementation. Companies are increasingly adopting Six Sigma in a bid to improve the quality of

More information

1. Dream, Mission, Vision and Values

1. Dream, Mission, Vision and Values 1. Dream, Mission, Vision and Values This document constitutes Chapter 1 of the Fundamental Texts of CGI Group Inc. It begins with the mission statement of the company and is followed by the vision, the

More information

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities

More information